FDA approves nasal sprays to treat migraine headaches CBS Boston

Boston, Massachusetts — There could soon be a brand new treatment option for those suffering from migraine headaches via nasal spray.

The FDA has approved Pfizer’s newest nasal spray, Zavzpret to treat acute migraine.

It is true that there are nasal sprays available on the market , however unlike many this spray is believed to be safe for those with high risk factors for heart disease and shouldn’t trigger overuse headaches similar to the way some medications might.

In research which examined the effectiveness of the spray, it was found to be better than a placebo when it came to alleviating pain and other migraine-related symptoms. Patients were more likely to experience normal functioning 30 minutes to two hours after using the spray.

The drug is expected to be available in July.

Mallika Marshall, MD

Mallika Marshall MD has been a Emmy award-winning journalist as well as a physician who been the HealthWatch Reporter for CBS Boston/WBZ-TV for more than 20 years. A physician who is Board Certified in both Internal Medicine and Pediatrics Dr. Marshall serves on staff at Harvard Medical School and practices at Massachusetts General Hospital at the MGH Chelsea Urgent Care and the MGH Revere Health Center which is where she’s currently at the frontline in caring for patients suffering from COVID-19. She also serves as an editor and host of Harvard Health Publications (HHP) the publishing arm that is part of Harvard Medical School.

RELATED ARTICLESMORE FROM AUTHOR